Dr. Jeffrey N. Greenspoon
Claim this profileJuravinski Cancer Centre at Hamilton Health Sciences
Studies Brain Tumor
Studies Limbic-predominant Age-related TDP-43 Encephalopathy
3 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Jeffrey N. Greenspoon is currently running
Stereotactic Radiosurgery vs. HA-WBRT + Memantine
for Brain Cancer
Stereotactic radiosurgery (SRS) is a commonly used treatment for brain tumors. It is a one-day (or in some cases two day), out-patient procedure during which a high dose of radiation is delivered to small spots in the brain while excluding the surrounding normal brain. Whole brain radiation therapy with hippocampal avoidance (HA-WBRT) is when radiation therapy is given to the whole brain, while trying to decrease the amount of radiation that is delivered to the area of the hippocampus. The hippocampus is a brain structure that is important for memory. Memantine is a drug that is given to help relieve symptoms that can be caused by WBRT, including problems with memory and other mental symptoms. Health Canada, the regulatory body that oversees the use of drugs in Canada, has not approved the sale or use of memantine in combination with WBRT to treat this kind of cancer, although they have allowed its use in this study.
Recruiting2 awards Phase 3
Radiation Therapy vs Observation
for Meningioma
This trial studies if radiation therapy helps prevent the return of grade II meningioma after surgery. Radiation therapy uses powerful x-rays to destroy any leftover cancer cells. The goal is to see if this improves patient outcomes compared to just monitoring them. Radiation therapy has shown success in stabilizing tumor growth and reducing recurrence risk.
Recruiting2 awards Phase 312 criteria
More about Jeffrey N. Greenspoon
Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Jeffrey N. Greenspoon has experience with
- Single Fraction Stereotactic Radiosurgery
- Fractionated Stereotactic Radiosurgery
- Clinical Observation
- Radiation Therapy
- Memantine
- Stereotactic Radiosurgery (SRS)
Breakdown of trials Jeffrey N. Greenspoon has run
Brain Tumor
Limbic-predominant Age-related TDP-43 Encephalopathy
Brain Metastasis
Anaplastic Meningioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey N. Greenspoon specialize in?
Jeffrey N. Greenspoon focuses on Brain Tumor and Limbic-predominant Age-related TDP-43 Encephalopathy. In particular, much of their work with Brain Tumor has involved Stage IV patients, or patients who are undergoing treatment.
Is Jeffrey N. Greenspoon currently recruiting for clinical trials?
Yes, Jeffrey N. Greenspoon is currently recruiting for 2 clinical trials in Hamilton Ontario. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey N. Greenspoon has studied deeply?
Yes, Jeffrey N. Greenspoon has studied treatments such as Single Fraction Stereotactic Radiosurgery, Fractionated Stereotactic Radiosurgery, Clinical Observation.
What is the best way to schedule an appointment with Jeffrey N. Greenspoon?
Apply for one of the trials that Jeffrey N. Greenspoon is conducting.
What is the office address of Jeffrey N. Greenspoon?
The office of Jeffrey N. Greenspoon is located at: Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario L8V 5C2 Canada. This is the address for their practice at the Juravinski Cancer Centre at Hamilton Health Sciences.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.